BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben-Shimol S, Dagan R, Givon-Lavi N, Avital D, Bar-Ziv J, Greenberg D. Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children. Clin Infect Dis 2020;71:177-87. [PMID: 31414125 DOI: 10.1093/cid/ciz768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Janapatla RP, Su L, Li H, Kuo K, Chien C, Hsiao C, Chiu C. Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.04.022] [Reference Citation Analysis]
2 Phillips MT, Warren JL, Givon-Lavi N, Tothpal A, Regev-Yochay G, Dagan R, Weinberger DM. Evaluating post-vaccine expansion patterns of pneumococcal serotypes. Vaccine 2020;38:7756-63. [PMID: 33164799 DOI: 10.1016/j.vaccine.2020.10.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Danino D, Van Der Beek BA, Givon-Lavi N, Greenberg D, Ben-Shimol S, Dagan R. Unravelling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time Series Analysis. Clin Infect Dis 2021:ciab413. [PMID: 34013338 DOI: 10.1093/cid/ciab413] [Reference Citation Analysis]
4 Chen Y, Roberts CS, Ou W, Petigara T, Goldmacher GV, Fancourt N, Knoll MD. Deep learning for classification of pediatric chest radiographs by WHO's standardized methodology. PLoS One 2021;16:e0253239. [PMID: 34153076 DOI: 10.1371/journal.pone.0253239] [Reference Citation Analysis]
5 Faingelernt Y, Dagan R, Givon-Lavi N, van der Beek BA, Ben-Shimol S, Shany E, Greenberg D. The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants. Vaccine 2022;40:568-73. [PMID: 34973848 DOI: 10.1016/j.vaccine.2021.12.025] [Reference Citation Analysis]
6 Gessner BD, Isturiz R, Snow V, Grant LR, Theilacker C, Jodar L. The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia. Expert Rev Vaccines 2021;20:269-80. [PMID: 33602035 DOI: 10.1080/14760584.2021.1889376] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hsiao A, Hansen J, Timbol J, Lewis N, Isturiz R, Alexander-Parrish R, McLaughlin JM, Gessner BD, Klein NP. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine. JAMA Netw Open 2022;5:e221111. [PMID: 35302634 DOI: 10.1001/jamanetworkopen.2022.1111] [Reference Citation Analysis]
8 Rivero-Calle I, Pardo Seco J, Raguindin PF, Alvez F, Gómez-Rial J, Salas A, Martinón Sanchez J, Martinón-Torres F. Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain. Hum Vaccin Immunother 2020;16:1446-53. [PMID: 31851569 DOI: 10.1080/21645515.2019.1690884] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Ben-Shimol S, Givon-Lavi N, Kotler L, Adriaan van der Beek B, Greenberg D, Dagan R. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerg Infect Dis 2021;27:150-60. [PMID: 33350916 DOI: 10.3201/eid2701.201178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]